Business Context and Reporting Period
This Form 8-K Current Report was filed by Surgery Partners, Inc. (SGRY) on January 10, 2025. The filing reports a corporate governance event involving the Board of Directors rather than financial performance results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on board composition changes and does not contain financial statements or operational metrics.
Material Changes
- Board Expansion: The Board increased the number of Class II directors from three to four.
- New Appointment: Dr. Laura L. Forese was elected to fill the new Class II director vacancy.
- Committee Assignment: Dr. Forese was appointed to the Compliance and Ethics Committee.
- Independence: The Board determined Dr. Forese is independent under Nasdaq listing standards.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding business operations. Regarding compensation, the Board stated that Dr. Forese's compensation will be materially consistent with other non-employee directors as described in the definitive proxy statement filed on April 25, 2024. Dr. Forese also entered into the Company's standard indemnification agreement.
Investor Verification Checklist
- Verify Dr. Laura L. Forese's professional background and qualifications via the press release filed as Exhibit 99.1.
- Review the definitive proxy statement filed on April 25, 2024, to confirm the specific compensation structure for non-employee directors.
- Confirm the expiration date of Dr. Forese's term (2026 annual meeting of stockholders).
- Check for any subsequent filings regarding the impact of this board change on the Compliance and Ethics Committee's operations.